Trademark: CX 2137199
Word
CX
Device Descrption:
LTRS IN RECTANGLE
ID
2137199
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
11 December 2017
Registration Date
30 October 2020
Renewal Date
11 December 2027
Owner(s)
Service
Goods and Services:
Class 5:
Diagnostic biomarker reagents for medical purposes, diagnostic preparations for medical purposes.
Diagnostic biomarker reagents for medical purposes, diagnostic preparations for medical purposes.
Class 10:
Medical test kits, devices, apparatuses, and analysis instruments for carrying out assays for medical purposes including prognosis, diagnosis and monitoring; medical test kits, devices, apparatuses and instruments for collection of samples for the purposes of medical prognosis, diagnosis and monitoring; blood and urine sampling and analysis systems; all of the aforementioned goods for the purpose of prognosis, diagnosis, detection or monitoring of the risk or presence of cancer, especially bladder cancer, gastric cancer, colorectal cancer, endometrial cancer, and melanoma.
Medical test kits, devices, apparatuses, and analysis instruments for carrying out assays for medical purposes including prognosis, diagnosis and monitoring; medical test kits, devices, apparatuses and instruments for collection of samples for the purposes of medical prognosis, diagnosis and monitoring; blood and urine sampling and analysis systems; all of the aforementioned goods for the purpose of prognosis, diagnosis, detection or monitoring of the risk or presence of cancer, especially bladder cancer, gastric cancer, colorectal cancer, endometrial cancer, and melanoma.
Class 44:
Health, medical and assessment, evaluation and diagnostic services, including the prognostic and diagnostic testing of biological samples especially blood and urine, including for the prognostic and diagnostic testing, monitoring and reporting of cancer, including bladder cancer, gastric cancer, colorectal cancer, endometrial cancer, and melanoma.
Health, medical and assessment, evaluation and diagnostic services, including the prognostic and diagnostic testing of biological samples especially blood and urine, including for the prognostic and diagnostic testing, monitoring and reporting of cancer, including bladder cancer, gastric cancer, colorectal cancer, endometrial cancer, and melanoma.